Mesalamine and Anxiolytic therapy for Women aged 20-29 (a phase IV clinical study of FDA data)

Summary:

Anxiolytic therapy is found for women aged 20-29 who take Mesalamine (mesalamine). This study is created by eHealthMe based on reports of 1,360 women aged 20-29 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Mesalamine when people have Anxiolytic therapy
Top conditions
Top co-used drugs
Top other side effects

On Apr, 14, 2026

1,360 women aged 20-29 reported to have side effects when taking Mesalamine.
Among them, 123 people (9.04%) have Anxiolytic therapy

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

What is Anxiolytic therapy?

Anxiolytic therapy is found to be associated with 4,625 drugs and 5,691 conditions by eHealthMe. Check the latest studies of Anxiolytic therapy.

Number of reports submitted per year:

Could Mesalamine cause Anxiolytic therapy in women aged 20-29?

Time on Mesalamine when people have Anxiolytic therapy *

Severity of Anxiolytic therapy

n/a

How people recovered from Anxiolytic therapy

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Birth Control: 8 people, 6.50%
Insomnia (sleeplessness): 5 people, 4.07%
Pain: 5 people, 4.07%
Hidradenitis (chronic disease of a type of sweat gland): 3 people, 2.44%
Gastric Ulcer (stomach ulcer): 3 people, 2.44%
Abdominal Pain Upper: 3 people, 2.44%
Osteoporosis (bones weak and more likely to break): 3 people, 2.44%
Indigestion: 2 people, 1.63%
Genital Herpes (herpes infection of genital): 2 people, 1.63%
Depression: 2 people, 1.63%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Humira: 69 people, 56.10%
Budesonide: 65 people, 52.85%
Elavil: 59 people, 47.97%
Methotrexate: 59 people, 47.97%
Metronidazole: 58 people, 47.15%
Ciprofloxacin Hydrochloride: 53 people, 43.09%
Flagyl: 32 people, 26.02%
Pentasa: 24 people, 19.51%
Prednisone: 20 people, 16.26%
Methotrexate Sodium: 13 people, 10.57%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Drug Ineffective: 71 people, 57.72%
Diarrhea: 19 people, 15.45%
Nausea (feeling of having an urge to vomit): 16 people, 13.01%
Abdominal Pain Upper: 15 people, 12.20%
Fatigue (feeling of tiredness): 14 people, 11.38%
Nausea And Vomiting: 14 people, 11.38%
Abdominal Pain: 13 people, 10.57%
Dizziness: 12 people, 9.76%
Weight Decreased: 11 people, 8.94%
Birth Control: 11 people, 8.94%

* Approximation only. Some reports may have incomplete information.

Do you take Mesalamine and have Anxiolytic therapy?

- Check whether Anxiolytic therapy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

Related studies:

Mesalamine and Anxiolytic therapy

How the study uses the data?

The study is based on (applicable) gender, age, mesalamine (the active ingredients of Mesalamine) and Mesalamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.